Acquiring an established referral-based specialty practice delivers immediate revenue, board-certified staff, and a proven referral network — but building from scratch gives you full control over culture and equipment. Here's how to weigh the tradeoff.
Veterinary specialty medicine is one of the most defensible and consistently growing segments in the $60B+ companion animal healthcare industry. Whether you're a PE-backed consolidator, a board-certified specialist ready for ownership, or a strategic acquirer expanding your geographic footprint, the core question is the same: do you buy an existing specialty practice with revenue, staff, and referral relationships already in place — or do you build a new one from the ground up? The answer depends heavily on your access to board-certified talent, tolerance for a 2–4 year ramp period, capital structure, and how quickly you need to generate returns. In a sector where fewer than 10,000 board-certified specialists exist nationally and established referral networks take years to build, the acquisition path carries significant structural advantages for most buyers — but the build path has merit for operators with unique talent in hand and a clearly underserved local market.
Find Veterinary Specialty Practice Businesses to AcquireAcquiring an established veterinary specialty practice gives you immediate access to revenue-generating specialists, a functioning referral pipeline, trained technical staff, and operational infrastructure. In a field where board-certified veterinarians are in severe national shortage and general practice referral relationships are deeply personal and slow to develop, buying sidesteps the hardest parts of building. A practice with $1.5M–$5M in revenue, EBITDA margins of 15–25%, and a diversified referral base from 20+ general practices can generate positive cash flow from day one with SBA 7(a) financing covering 80–90% of the purchase price.
PE-backed veterinary consolidators, individual board-certified specialists seeking ownership without starting from zero, and strategic acquirers expanding into new metro markets who need immediate revenue contribution and an established referral network.
Building a veterinary specialty practice from scratch — sometimes called a de novo — makes sense only under a narrow set of conditions: you have a board-certified specialist committed to joining, a clearly underserved market with no competing specialty group, and patient capital willing to fund a 2–4 year ramp to profitability. The barriers to entry are steep: recruiting specialists in a nationally supply-constrained field, procuring and installing high-cost diagnostic equipment, and cultivating referral relationships with general practitioners who are cautious about sending cases to an unproven clinic. For most buyers, de novo is the harder road — but for operators with the right talent and market conditions, it avoids acquisition premiums and delivers a purpose-built operation.
Well-capitalized operator-owners who have a committed board-certified specialist relationship secured in advance, have identified a demonstrably underserved specialty market with no existing competition, and can absorb a 2–4 year ramp without pressure for near-term returns.
For most buyers entering veterinary specialty medicine — whether PE-backed consolidators, individual specialists seeking ownership, or strategic acquirers — acquisition is the clearly superior path. The national shortage of board-certified specialists, the relationship-driven nature of referral networks, and the capital intensity of diagnostic equipment all create compounding advantages for buying an established practice over building one. The core risk in acquisition — specialist retention and referral continuity post-close — is manageable with the right deal structure: earnout provisions tied to referral volume, equity rollovers that keep the selling specialist engaged, and retention bonuses for key clinical staff. Building from scratch is a defensible strategy only when a committed specialist is already secured and the target market is genuinely underserved with no competing specialty group. In every other scenario, the 2–4 year ramp, the capital burn, and the referral network development challenge make de novo an unnecessarily difficult path when acquisition delivers immediate cash flow, proven infrastructure, and a faster route to platform growth.
Do you have a board-certified specialist committed in writing to join your new practice — or are you assuming you can recruit one in a nationally supply-constrained market?
Is there an established specialty practice available for acquisition in your target market at a reasonable multiple, or is the market so fragmented or thinly traded that a de novo is the only viable entry point?
Can you absorb 24–48 months of cash burn and capital deployment without returns if you build, or does your capital structure require near-term revenue and positive cash flow?
Have you stress-tested the referral network of any acquisition target — specifically, what percentage of revenue is concentrated in the top five referring practices and what happens to that volume if ownership changes?
What is your primary value creation thesis — operational improvement and add-on acquisition scaling, or greenfield market capture — and which path aligns better with that thesis given your timeline and capital availability?
Browse Veterinary Specialty Practice Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Most veterinary specialty practices with $1.5M–$5M in revenue trade at 4.5x–7.5x EBITDA, depending on specialist depth, referral diversification, and equipment condition. A practice generating $500K in EBITDA might sell for $2.25M–$3.75M. Practices with multiple board-certified specialists across disciplines, EBITDA margins above 20%, and diversified referral networks from 20+ general practices command multiples at the higher end of that range.
Yes. Veterinary specialty practices are SBA 7(a) eligible, and this is one of the most common financing structures for individual buyer acquisitions. SBA financing typically covers 80–90% of the purchase price, requiring a buyer equity injection of 10–15%. Lenders experienced in veterinary practice acquisitions will underwrite based on historical revenue, EBITDA, specialist contracts, and equipment condition. Clean DEA history and organized financials significantly strengthen SBA approval prospects.
Specialist retention is the single greatest risk. If the board-certified veterinarian who generates the majority of revenue departs post-close — whether to join a competitor, start their own practice, or retire — referral volume can collapse rapidly since general practitioners route cases to individuals, not businesses. Mitigating this risk requires reviewing employment contracts and non-competes before closing, structuring earnouts tied to specialist tenure, and considering equity rollovers that keep the selling specialist financially engaged in the practice's success.
Plan for 12–18 months before generating meaningful revenue and 24–48 months to reach EBITDA breakeven. The timeline is driven primarily by three factors: specialist recruitment (the hardest constraint given national shortage), diagnostic equipment procurement and installation (MRI and CT lead times alone can run 6–12 months), and referral network development with general practice vets who are cautious about routing cases to new, unproven clinics. Operators who enter de novo with a committed specialist already secured can compress this timeline modestly.
Focus first on specialist employment contracts — confirm assignability, non-compete terms, and retention risk post-close. Then analyze referral source concentration: if the top three referring practices represent more than 40% of revenue, that's a significant risk flag. Audit DEA controlled substance compliance records and state veterinary board licensing status, as violations can jeopardize operations post-close. Commission an independent appraisal of major diagnostic equipment (MRI, CT, ultrasound) to assess condition and remaining useful life. Finally, review accounts receivable aging and pet insurance payor mix to understand revenue quality and collection efficiency.
PE-backed consolidators typically apply higher multiples — sometimes above 7x EBITDA — because they're acquiring platform assets or geographic fill-ins for existing networks, and they benefit from operational leverage across multiple sites. They also place premium value on multi-specialist practices that reduce single-person revenue dependency and on practices with proprietary or long-standing referral networks that are difficult for competitors to displace. Individual buyers using SBA financing generally underwrite more conservatively and focus more heavily on post-close cash flow coverage of debt service, which often means targeting practices with lower multiples and cleaner transition profiles.
More Veterinary Specialty Practice Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers